Tatiana V. Kharitonova
Saint Petersburg, SPE, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Assessment of the efficacy of Cytoflavin in the acute phase of ischemic stroke: a systematic review and meta-analysis
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: August 07, 2026
Fortelyzin in the treatment of acute ischemic stroke in patients ≥80 years old: data from the observational study FORPI registry
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: April 15, 2026
A multicenter, international observational study of the efficacy of Cytoflavin solution for intravenous administration in patients with ischemic stroke not receiving reperfusion therapy
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: April 15, 2026
Fortelizin in bridging therapy of acute ischemic stroke: data from the observational study FORPI registry
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: March 05, 2026
Fortelyzin for acute ischaemic stroke treatment in an extended (4.5 to 24 hours from the onset of symptoms) time window: data from the observational study FORPI registry
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: February 09, 2026
Fortelyzin for acute ischaemic stroke treatment: an open, prospective, non-interventional, observational study FORPI registry
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: January 12, 2026
A multicenter, international, randomized, single-blind, placebo-controlled study of the efficacy and safety of inosine-nicotinamide-riboflavin-succinic acid in the acute period of traumatic brain injury in adults.
Journal: Frontiers in neurology
Published: August 11, 2025
Results of a clinical and experimental study of the safety and efficacy of Cytoflavin in combination with reperfusion therapy for ischemic stroke
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: September 01, 2023
Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER).
Journal: BMJ open diabetes research & care
Published: January 24, 2022
Retrospective analysis of endovascular thrombectomy in anterior cerebral circulation out of 6-hours «therapeutic window» in regional vascular centers of Saint-Petersburg
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: August 14, 2020
Outcomes of endovascular thrombectomy for acute stroke in regional vascular centers of a metropolis (St.-Petersburg)
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: January 01, 2018
Last Updated: 09/26/2026